Form 4 for ENOV Enovis CORP
Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-25 · accession 0001209191-22-014360 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-03-01 | 2022-02-25+ | ENOV | Hix Christopher M | EVP, CFO | S - Sale | $40.62 | -33.3K | 145.3K | -19% | -$1.35M |
| 2022-03-01 | 2022-02-25 | ENOV | Hix Christopher M | EVP, CFO | A - Grant | $0.00 | +67.9K | 176.4K | +63% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $.001 | 2022-02-25 | S | D | 2,079 | $42.18 | 108,509 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs"). |
| 2 | Common | Common stock, par value $.001 | 2022-02-25 | A | A | 67,915 | $0.00 | 176,424 | D | — | — | (F2) Reflects the certification of the performance criteria for PRSUs previously awarded in 2019. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2020 Fiscal Year-End" table on page 42 of Colfax Corporation's 2021 Proxy Statement as filed with the Securities and Exchange Commission ("SEC") on April 1, 2021. |
| 3 | Common | Common stock, par value $.001 | 2022-02-28 | S | D | 100 | $41.72 | 145,217 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs"). |
| 4 | Common | Common stock, par value $.001 | 2022-02-28 | S | D | 19,330 | $40.11 | 157,094 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs"). (F3) The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.69 to $40.67, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4. |
| 5 | Common | Common stock, par value $.001 | 2022-02-28 | S | D | 11,777 | $41.18 | 145,317 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs"). (F4) The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.69 to $41.54, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4. |